# Impact of Propranolol on the Prognosis of Patients With Decompensated Cirrhosis and MELD Score > 9

> **NCT07652203** · NA · NOT_YET_RECRUITING · sponsor: **General Hospital of Shenyang Military Region** · enrollment: 466 (estimated)

## Conditions studied

- Cirrhosis

## Interventions

- **OTHER:** conventional therapy
- **DRUG:** propranolol

## Key facts

- **NCT ID:** NCT07652203
- **Lead sponsor:** General Hospital of Shenyang Military Region
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09
- **Primary completion:** 2027-07
- **Final completion:** 2028-07
- **Target enrollment:** 466 (ESTIMATED)
- **Last updated:** 2026-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07652203

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07652203, "Impact of Propranolol on the Prognosis of Patients With Decompensated Cirrhosis and MELD Score > 9". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07652203. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*